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Abstract
A number of individuals and organizations have considerable influence over the selection of global health priorities 
and strategies.  For some that influence derives from control over financial resources.  For others it comes from 
expertise and claims to moral authority—what can be termed, respectively, epistemic and normative power.  In 
contrast to financial power, we commonly take for granted that epistemic and normative forms of power are legitimate. 
I argue that we should not; rather we should investigate the origins of these forms of power, and consider under what 
circumstances they are justly derived.
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Power is exercised everywhere in global health although its presence may be more apparent in some instances than others. We commonly recognize an attempt 
to exert it when a pharmaceutical company insists it will 
invest in a country only if the government alters patent 
protection laws, when the World Bank demands as a loan 
condition that a borrowing government undertakes major 
health sector reforms, and when a bilateral donor allocates 
health aid according to its geopolitical interests rather than 
humanitarian need. By contrast, we may not recognize its 
exertion—or not call it such—when a Lancet special issue 
promotes a particular strategy to address malnutrition, when 
the Institute for Health Metrics and Evaluation (IHME) 
disseminates a new version of its Global Burden of Disease 
(GBD) study, or when North American AIDS activists press 
to ensure inclusion of universal access to anti-retroviral drugs 
in global development goals. Yet if we understand power to 
be the production of effects that shape the capacity of others 
to determine their own circumstances or fates, as political 
scientists have argued (1), then all these instances count as 
attempts to exert power.
We traditionally understand power in compulsory terms, 
as the direct control of one actor over another. The classic 
definition is by Robert Dahl (2): “A has power over B to the 
extent that he can get B to do something that B would not 
otherwise do”. The pharmaceutical company example above is 
an instance. But there are several other forms. Among others is 
structural power (1,3): how we define ourselves in relationship 
to one another, in ways that enhance the capacities of some 
and limit those of others. A stark historical example is master 
and slave. Also, there is productive power (1): how we create 
meaning, particularly through the use of categories that lead 
us to think about the world in some ways but not others.
In global health we see structural power at work in the 
existence of a cadre of individuals—medical professionals, 
development economists, advocacy experts and others—
who offer advice to governments of low-income countries 
presumed to be in need of their input. And we see productive 
power at work as they create concepts for thinking about 
health priority-setting, such as burden of disease, treatment 
cost-effectiveness and the right to receive care.
In seeking to exert power, actors may claim expertise 
concerning the biomedical causes of a condition, 
its prevalence, broader determinants of health, appropriate 
policy responses, or interventions needed to address or 
avert illness. Examples include officials and researchers 
in universities and international organizations such as the 
World Health Organization (WHO) and World Bank. Actors 
may also claim insight concerning ethical principles we ought 
to follow as we make decisions about improving population 
health—for instance human rights lawyers, and activists 
promoting sexual and reproductive health or population 
stabilization. Each of these two kinds of assertions—epistemic 
and normative—invoke both structural and productive 
power: an implicit or explicit declaration about 1) the status of 
the claimant vis-à-vis those whose behavior he or she intends 
to shape, and 2) the validity of the categories he or she uses to 
express the needed changes.
In contrast to power that comes from control over financial 
resources, we commonly take these forms of power to be 
legitimate, by virtue of their grounding in knowledge or 
humanitarian motives. I argue that we should not do so, but 
rather inquire into the sources of such power, and consider 
the circumstances under which its exertion is justifiable.  
There are several reasons to raise such questions. First, 
these forms of power are widespread, yet little analyzed or 
understood. Why do some individuals become recognized 
as global health experts? Why are some organizations (for 
instance Doctors without Borders) afforded legitimacy while 
others are frequently attacked (for instance the World Bank)? 
Do these differences arise simply as a result of the behavior of 
the actors, or are they due to more complex social processes? 
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Second, the exertion of these powers raises normative 
questions surrounding legitimacy and accountability. On 
what basis does one acquire a right to exert such power? Is 
it sufficient to show that one is motivated by a humanitarian 
impulse and/or has made a positive difference, or must we 
consider additional criteria surrounding fair process and 
deliberation? (4). And how should we hold those who exert 
power accountable? Third, far from being in opposition, 
improving health requires exerting epistemic and normative 
power, particularly to expand service access and to alter social 
structures that lead to illness and death. Many in the global 
AIDS movement operate from just such a premise.  
Three examples—concerning leadership in the health metrics 
field, the emergence of the Lancet as a global health actor, and 
the formation of the post-2015 health development goals—
help to illustrate why investigating epistemic and normative 
power may be useful:
1. There is now significant contestation concerning 
leadership in the health metrics field. Much is due to the 
emergence of the IHME, a University of Washington-
based, Gates Foundation-supported non-governmental 
organization, formed in 2007. Its signature products are 
GBD studies, which the Institute states aim to provide 
impartial information on health loss due to variety of 
conditions (5). The formation of the IHME represented 
a challenge to the WHO, among other organizations, 
which had traditionally served as a global leader in 
the production of health metrics (6). Several major 
disagreements have emerged between the two, including 
heated conflicts over global malaria estimates (7). While 
there is no obvious reason to question the Institute’s 
commitment to the conduct of impartial science, IHME 
and its GBD studies have been criticized on a number of 
grounds, several of which form the backdrop for conflict 
with the WHO over leadership (6,8–10). These include 
providing insufficient information about data sources, 
excluding important disease sub-categories, devaluing 
the lives of people living with disabilities, undertaking 
inadequate external consultation, and acting as a 
competitor rather than a collaborator in the health metrics 
field. These critiques, and contestation with the WHO, 
suggest that the exercise of epistemic power is a central 
issue in a seemingly impartial, neutral undertaking: the 
production of data concerning disease burden. 
2. Over the past two decades a medical journal—the 
Lancet—has emerged as one of the most powerful actors 
in global health. One of the world’s most highly cited 
publications, the Lancet’s heavy involvement in global 
health emerged in the late 1990s, when it initiated a 
special series on global health. To date the journal has 
published more than 100 such series (http://www.
thelancet.com/global-health-series), several backed 
by donors. Most recently, the Lancet has organized a 
number of commissions intended to spur action on 
global health issues, including the health implications of 
climate change and health investment. These series and 
commissions have influenced policy in low- and middle-
income countries (11–13).  By organizing these series and 
commissions, the Lancet has emerged as a strong voice 
in global health, and as a powerful convening forum for 
scholars and officials to express their ideas on what the 
world should do to advance health—one that potentially 
rivals traditional venues such as the World Health 
Assembly in its visibility and influence. That being said, 
unlike other publication types there are valuable checks 
on what appears in the journal, as articles must go through 
peer review, forcing authors to respond to critiques and 
opposing points of view. Still, the emergence of the 
Lancet in such roles raises some interesting questions 
concerning the exertion of epistemic and normative 
power. What are the benefits and disadvantages of a 
medical journal undertaking such activities in the global 
health field? Which issues are more likely to receive a 
hearing, and which may be neglected? Whose voices are 
privileged by this phenomenon? Whose are missed? How 
is the power of other global health actors enhanced or 
diminished, including researchers in medical and public 
health schools, the WHO, the World Bank, the Global 
Fund, and civil society movements?
3. The Millennium Development Goals (MDGs) expire in 
2015. Three of the eight focus on health (goal four on 
child survival, five on maternal survival and six on HIV/
AIDS and other major diseases). The United Nations 
has convened several meetings to consider which health 
objectives to include in a set of post-2015 development 
goals. A task force report on these consultations suggests 
disagreement among actors concerning whether the 
new health goals should focus on achieving new MDG-
like objectives, ensuring universal health coverage, 
facilitating an increase in healthy life-years, or some 
combination of these objectives (14). Most recently, 
there are proposals to include health as one of seventeen 
Sustainable Development Goals (SDGs), with targets 
that pertain to each of these three objectives. Unlike 
the MDGs, which were designed by a small group of 
officials in the UN secretariat (15), the Task Force Team 
carried out numerous consultations with governments 
and other actors (http://www.worldwewant2015.org/
health). It is unclear, however, how certain proposals got 
on the table and others did not (16), and by what process 
final decisions on priorities will be made. Like the two 
examples above, the formation of the post-2015 health 
development goals raises interesting questions about 
the exercise of epistemic and normative power in global 
health: specifically, whose voices matter most in shaping 
global health priorities, and how they exert influence.
In sum, although some of the actors in these three 
undertakings may argue otherwise, there are strong reasons 
to believe that more than careful, rational, pluralistic 
deliberation is involved in each. Each undertaking may involve 
the exercise of structural power by setting up particular 
individuals as global health experts whose advice ought to 
be accepted by allegedly information-deprived low-income 
governments. Each may be exercising productive power by 
shaping a global discourse surrounding particular categories 
to use to think about health, and why we should pursue health 
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development in the first place. Specifically, the IHME may be 
shaping a global discourse focused on health burden rather 
than rights or social determinants. The Lancet may be setting 
itself up as an alternative forum for global health deliberation 
and signaling to the world which issues should be prioritized 
and which individuals should be listened to in order to make 
such a determination. And the United Nations post-2015 
health development goal-setting process may be privileging 
some issues whose backers are particularly adept at global 
lobbying and advocacy, while sidelining other issues whose 
backers lack such access or capacity. This is not to suggest that 
these are all examples of illegitimate uses of power—in several 
respects they may be vast improvements over past priority-
setting processes and may offer voice to those who previously 
lacked expression. It is to suggest that these examples indicate 
that there is far more to global health decision-making than 
careful consideration of evidence, and a critical need to 
investigate how epistemic and normative power get exercised 
in the global health field. 
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